Surgical revascularization of hibernating myocardium: the known and the unknown

Abstract

Coronary artery disease (CAD) represents the leading cause of chronic heart failure in developed countries. Ischemic heart failure is mainly characterized by impairment of left ventricle systolic function which can result from scarring of myocardium after myocardial infarction, stunning myocardium and hibernating myocardium. Hibernating myocardium represents a cause of ischemic left ventricular dysfunction amenable to recovery after revascularization. Several viability imaging modalities are available but their role in the clinical decision-making process and the prognostic value of viability in patients undergoing revascularization are still debated. When available, cardiac magnetic resonance or positron emission tomography should be preferred over the others as they show higher performance in terms of sensitivity and higher spatial resolution. Several observational studies have supported a positive prognostic value to the presence of viable myocardium for patients undergoing revascularization. This was not confirmed in randomized clinical trials. This lack of evidence does not support a precise role of viability assessment in the clinical decision-making process, and therefore, myocardial viability should be only one of the several factors considered in the clinical decision-making process.

Keywords

Hibernating myocardium / viability imaging / surgical revascularization

References

[1] Lippi G.Global epidemiology and future trends of heart failure..AME Med J2020;5:15-15

[2] Salim VS,Benjamin EJ.Heart disease and stroke statistics-2020 update: a report from the American Heart Association..Circulation2020;141:e139-596

[3] Khan MA,Mustafa H.Global epidemiology of ischemic heart disease: results from the global burden of disease study..Cureus2020;12:e9349 PMCID:PMC7384703

[4] Briceno N,Lumley M.Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation..Heart2016;102:397-406

[5] Allman KC,Hachamovitch R.Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis..J Am Coll Cardiol2002;39:1151-8

[6] Schinkel AF,Poldermans D,Ferrari R.Hibernating myocardium: diagnosis and patient outcomes..Curr Probl Cardiol2007;32:375-410

[7] Camici PG,Rimoldi OE.Stunning, hibernation, and assessment of myocardial viability..Circulation2008;117:103-14

[8] Orlandini A,Pascual A.Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction and coronary artery disease: a meta-analysis of non-randomized and randomized studies..Int J Cardiol2015;182:494-9

[9] Velazquez EJ,Jones RH.Coronary-artery bypass surgery in patients with ischemic cardiomyopathy..N Engl J Med2016;374:1511-20 PMCID:PMC4938005

[10] Rahimtoola SH.The hibernating myocardium..Am Heart J1989;117:211-21

[11] Heusch G.The regional myocardial flow-function relationship: a framework for an understanding of acute ischemia, hibernation, stunning and coronary microembolization. 1980..Circ Res2013;112:1535-7

[12] Vogt AM,Nef H,Kübler W.Increased glycolysis as protective adaptation of energy depleted, degenerating human hibernating myocardium..Mol Cell Biochem2003;242:101-7

[13] Elsässer A,Klövekorn WP.Hibernating myocardium: an incomplete adaptation to ischemia..Circulation1997;96:2920-31

[14] Heusch G.Hibernating myocardium..Physiol Rev1998;78:1055-85

[15] Cwajg JM,Nagueh SF.End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography..J Am Coll Cardiol2000;35:1152-61

[16] Senior R.Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the “biphasic” response of wall thickening during low and high dose dobutamine infusion..J Am Coll Cardiol1995;26:26-32

[17] Jamiel A,Ahmed AM,Al-Mallah MH.The role of myocardial viability in contemporary cardiac practice..Heart Fail Rev2017;22:401-13

[18] Pellikka PA,Elhendy AA,Sawada SG.American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography..J Am Soc Echocardiogr2007;20:1021-41

[19] Shah BN,Senior R.The hibernating myocardium: current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era..Eur Heart J2013;34:1323-36

[20] Roes SD,Lamb HJ,de Roos A.Validation of echocardiographic two-dimensional speckle tracking longitudinal strain imaging for viability assessment in patients with chronic ischemic left ventricular dysfunction and comparison with contrast-enhanced magnetic resonance imaging..Am J Cardiol2009;104:312-7

[21] Kim RJ,Rafael A.The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction..N Engl J Med2000;343:1445-53

[22] Romero J,Gonzalez W.CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease: a meta-analysis of prospective trials..JACC Cardiovasc Imaging2012;5:494-508

[23] Chen Y,Jin H.Role of Mmyocardial extracellular volume fraction measured with magnetic resonance imaging in the prediction of left ventricular functional outcome after revascularization of chronic total occlusion of coronary arteries..Korean J Radiol2019;20:83-93 PMCID:PMC6315067

[24] Kidambi A,Uddin A.Myocardial extracellular volume estimation by CMR predicts functional recovery following acute MI..JACC Cardiovasc Imaging2017;10:989-99 PMCID:PMC5593809

[25] Stathogiannis K,Rashedi N,Patel AR.Regional myocardial strain by cardiac magnetic resonance feature tracking for detection of scar in ischemic heart disease..Magn Reson Imaging2020;68:190-6

[26] Baer FM,Schneider CA.Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization..J Am Coll Cardiol1998;31:1040-8

[27] Thornhill RE,Wisenberg G.The assessment of myocardial viability: a review of current diagnostic imaging approaches..J Cardiovasc Magn Reson2002;4:381-410

[28] Wagner A,Holly TA.Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study..Lancet2003;361:374-9

[29] Udelson JE,Metherall J.Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi..Circulation1994;89:2552-61

[30] Madsen S,Lauritsen KM,Tolbod LP.Myocardial viability testing by positron emission tomography: basic concepts, mini-review of the literature and experience from a tertiary PET center..Semin Nucl Med2020;50:248-59

[31] Neumann FJ,Ahlsson A.2018 ESC/EACTS Guidelines on myocardial revascularization..Eur Heart J2019;40:87-165

[32] Beanlands RS,Huszti E.F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)..J Am Coll Cardiol2007;50:2002-12

[33] Mc Ardle B,Nichol G.Long-term follow-up of outcomes with F-18-Fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction secondary to coronary disease..Circ Cardiovasc Imaging2016;9:e004331

[34] Abraham A,Williams KA.18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial..J Nucl Med2010;51:567-74

[35] Cleland JG,Freemantle N.The heart failure revascularisation trial (HEART)..Eur J Heart Fail2011;13:227-33

[36] Velazquez EJ,Deja MA.Coronary-artery bypass surgery in patients with left ventricular dysfunction..N Engl J Med2011;364:1607-16 PMCID:PMC3415273

[37] Bonow RO,Lee KL.Myocardial viability and survival in ischemic left ventricular dysfunction..N Engl J Med2011;364:1617-25 PMCID:PMC3290901

[38] Kloner RA.Stunned and hibernating myocardium: where are we nearly 4 decades later?.J Am Heart Assoc2020;9:e015502 PMCID:PMC7033879

[39] O’Meara E,Wells GA.Alternative imaging modalities in ischemic heart failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial..Trials2013;14:218 PMCID:PMC3729711